Sydnee Gould is a Ph.D. candidate in UC Berkeley's Molecular and Cellular Biology program. She received her B.S. in Translational Biomedical Sciences from Rowan University, where she worked in Dr. Claude Krummenacher's lab screening drugs to block herpes entry proteins. Following graduation, she spent two years at the NIH in Dr. Daniel Barber's lab studying mucosal-associated invariant T cells in COVID-19, tuberculosis, and co-infection models. In the Cox and Stanley labs, Sydnee focuses on tuberculosis meningitis, working to better understand bacterial and host pathways responsible for susceptibility to this neglected disease. She is passionate about mentorship and teaching as methods to break down barriers for young scientists pursuing STEM careers.